Breaking News: Zealand Pharma Shares Exciting Update on Dasiglucagon for Congenital Hyperinsulinism in the U.S.

Welcome to the Zealand Pharma Update! Company Announcement No. 48 / 2024 Zealand Pharma has just provided a U.S. regulatory update on dasiglucagon in congenital hyperinsulinism. The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for dasiglucagon in CHI for up to three weeks of dosing due to the timing…

Read More

Paragon 28 Class Action Commences: Johnson Fistel Encourages Shareholders to Seek More Information on Potential Loss Recovery

Charmingly Eccentric: A Look at Paragon 28, Inc. Class Action Lawsuit Denver Law Office Announces Class Action Lawsuit on Behalf of Paragon 28, Inc. Investors SAN DIEGO, Oct. 08, 2024 (GLOBE NEWSWIRE) The Denver Law Office of Johnson Fistel, LLP has announced a class action lawsuit on behalf of investors of Paragon 28, Inc. (NYSE:…

Read More

Norwood Financial Corp Declares Cash Dividend: A Heartfelt Announcement for Investors

Investing in Norwood Financial Corp: A Wise Decision Financial Stability and Generous Dividends When James O. Donnelly, President and CEO of Norwood Financial Corp, announced a $0.30 per share cash dividend, shareholders could not have been more pleased. This hefty dividend, payable on November 1, 2024, showcases the company’s commitment to shareholders and financial stability….

Read More

Update on Sale of Sabliere Property: Inovalis Real Estate Investment Trust Shares Latest News

Inovalis REIT Announces Sale of Single Asset Introduction Today, Inovalis Real Estate Investment Trust (the “REIT”) (TSX: INO.UN) made an official announcement regarding the sale of a single asset located at 24-26, Rue Bénard – 25, Rue Hyppolite Maind. This decision comes after several press releases and a special meeting of unitholders held on September…

Read More